Key Takeaways
- • Coatue Management was expected to invest up to US$1 billion (about $1.43 billion, per the source's conversion) in Firmus but allocated less than US$100 million for new shares, according to three people involved in the discussions.
- • The reduced allocation, far below the expected commitment, is the central element behind the report's framing of a Firmus funding setback as a "flop" driven by the San Francisco investment firm's reluctance.
- • Three sources familiar with the talks requested anonymity because they were not authorised to comment publicly, so the details remain unconfirmed by the companies or Coatue.
Summary
Coatue Management, the San Francisco-based investment firm, was expected to spend up to US$1 billion, roughly $1.43 billion as converted in the original report, to buy shares in Firmus. Instead, the firm allocated less than US$100 million for new shares, according to three people involved in the discussions. The sources asked not to be named because they were not authorised to comment.
The report characterises the outcome as a flop for Firmus, attributing it to the cold feet of Coatue, one of the most prominent growth-stage investors in the technology sector. The gap between the anticipated commitment and the amount ultimately allocated is substantial, roughly a tenth or less of the expected figure, and it raises questions about the level of institutional appetite for the company's share sale.
The original article does not include a company statement from Firmus or Coatue, and the reported figures rest on anonymous sourcing. Institutional investors tracking the transaction should treat the allocation amounts as reported rather than confirmed until further disclosure.
The report characterises the outcome as a flop for Firmus, attributing it to the cold feet of Coatue, one of the most prominent growth-stage investors in the technology sector. The gap between the anticipated commitment and the amount ultimately allocated is substantial, roughly a tenth or less of the expected figure, and it raises questions about the level of institutional appetite for the company's share sale.
The original article does not include a company statement from Firmus or Coatue, and the reported figures rest on anonymous sourcing. Institutional investors tracking the transaction should treat the allocation amounts as reported rather than confirmed until further disclosure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.